FIELD: medicine. SUBSTANCE: proposed agent is 4-oxahomoadamantan-1-ol-5-one that is used as humoral immunity stimulating agent. This agent acts on antigen-dependent phase of humoral response. Agent is used for correction of immunodeficiency state, for treatment of sickness associated with the decreased functional activity and amount of β-lymphocytes. EFFECT: enhanced effectiveness of agent. 6 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT SHOWING IMMUNOSTIMULATING EFFECT | 1995 |
|
RU2093162C1 |
AGENT POSSESSING IMMUNOSTIMULATING ACTIVITY | 2006 |
|
RU2311918C1 |
MEDICATION POSSESSING IMMUNOSTIMULATION ACTION | 2008 |
|
RU2406517C2 |
2,3-DIMETHOXY-15-METHYL-8,16-DIAZAGONA-1,3,5(10),13-TETRAENE-12,15-DIONE POSSESSING IMMUNOSTIMULATING, ANTIAGGREGATION AND ANTIINFLAMMATION ACTIVITY | 0 |
|
SU1088349A1 |
MEDICATION, WHICH POSSESES IMMUNOSTIMULATING ACTIVITY | 2009 |
|
RU2403054C1 |
IMMUNOMODULATOR | 2003 |
|
RU2253447C1 |
MEDICATION POSSESSING IMMUNOSTIMULATION ACTION | 2008 |
|
RU2406519C2 |
IMMUNOMODULATING AGENT | 1993 |
|
RU2108100C1 |
METHOD OF COLD-ASSISTED STIMULATION HUMORAL AND CELLULAR IMMUNITY | 1996 |
|
RU2142809C1 |
IMMUNOSTIMULANTS | 2008 |
|
RU2385732C1 |
Authors
Dates
1997-04-20—Published
1993-03-17—Filed